Saul Ewing Bolsters Los Angeles Team with Seasoned Employment Litigators

Saul Ewing, a high-profile law firm, has recently strengthened its Los Angeles arm by hiring two experienced employment litigators, Jessica E. Bradley and Kenneth M. Jones. The firm made this announcement on Wednesday. Bradley and Jones share a rich history of practicing as litigators and trial lawyers, specializing in employment disputes. Their array of professional…

Read More

State Privacy Laws: Insufficient Protection Amidst Growing Cybersecurity Concerns

In light of persistent inaction at the national level, states have taken the initiative to pass their own versions of cybersecurity and privacy laws. However, these efforts are plagued by problems that arguably worsen the landscape of these issues. Technological innovations have raced past legislative attempts to supervise and monitor them, leading to rising instances…

Read More

Maryland Workers’ Compensation Law Reforms: Bills Impacting Child Support and Occupational Disease Definitions

In an important update for legal professionals active in the workers’ compensation sphere, Maryland’s workers’ compensation law could see significant changes following the introduction of three new bills. With an emphasis on reconsidering the distribution of net recovery and redefining occupational diseases, these new legislative proposals will likely have a considerable impact on current and…

Read More

Decade After Actavis Ruling: Lasting Impacts on Pharmaceutical Antitrust Law and Patent Strategies

Reflecting on a decade subsequent to the consequential Supreme Court decision in Federal Trade Commission v. Actavis, it’s clear that this ruling fundamentally reshaped pharmaceutical antitrust law, by simultaneously defining “reverse payment settlements” and affirming that antitrust liability can apply to these settlements. Initially aiming to steer clear of instant condemnation of such settlements, the…

Read More

California Senate Bill 235 Revolutionizes Civil Discovery Process: Streamlining and Reducing Burden for Litigants

In the ever-evolving legal landscape, each new enactment or amendment holds potential for significantly altering processes and outcomes for litigants. In recent years, California has become a key jurisdiction for taking the lead in such developments. One such significant change is embodied in Senate Bill 235 (CA SB235), signed into law by Governor Gavin Newsom…

Read More

GSK v Teva Fallout: Induced Infringement, Skinny Labels, and Implications for Pharma Litigation

Last year, the Supreme Court made its decision to refuse the petition for certification in the landmark case GlaxoSmithKline v Teva Pharmaceuticals USA, widely known as GSK v Teva. The ripple effects of this denial have continued making waves within the legal community, particularly in the context of induced infringement claims and litigation strategies against…

Read More

Analyzing Federal Reserve Board’s Latest Papers: Navigating Market Stress and Stock Return Decomposition

In the realm of financial regulation, every day presents a new development. Here’s the rundown for Thursday, March 24, 2022. Sharp-eyed professionals will have noted two key releases from the Federal Reserve Board on March 23, which warrant a closer examination. First among these is a paper conspicuously titled “Moldy Lemons and Market Shutdowns”. This…

Read More

Rising PFAS Litigation Highlights Importance of Truthful Advertising in Consumer Products

As general awareness of per- and polyfluoroalkyl substances (PFAS) has risen in recent years, so too have the corresponding legal implications. Courts have seen an upswing in civil lawsuits claiming false and misleading advertising in marketing statements for consumer products, according to recent reports. This trend has been particularly noticeable in lawsuits filed in 2021…

Read More

Monsanto Roundup Controversy Intensifies as Trials Begin and MOVEit Data Breach Cases Relocate

Legal professionals have been keeping a close eye on a trio of ongoing trials surrounding controversial agrochemical and agricultural biotechnology corporation, Monsanto. The company’s product, Roundup, which is a widely used herbicide, is at the center of the controversy, with claims of it potentially being linked to cancer. At the same time, MOVEit, a managed…

Read More